US 7807168
Selection of human TNFα specific antibodies
granted A61PA61P37/00
Quick answer
US patent 7807168 (Selection of human TNFα specific antibodies) held by VACCINEX, INC. expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61P, A61P37/00